Características clínicas y tratamiento farmacológico de los pacientes con insuficiencia cardíaca en una cohorte de atención primaria

Características clínicas y tratamiento farmacológico de los pacientes con insuficiencia cardíaca en una cohorte de atención primaria

Resumen: Objetivo: Caracterizar los pacientes con insuficiencia cardíaca (IC) en atención primaria (AP), y describir sus características sociodemográficas, clínicas y tratamiento farmacológico. Diseño: Estudio descriptivo de cohorte. Emplazamiento: Sistema de Información para el Desarrollo de la In...

Full description

Saved in:

Bibliographic Details
Main Authors:	Maria Giner-Soriano, Ramon Monfà, Roser Vives, Silvia Fernández-García, Antoni Vallano, Rosa Morros
Format:	Article
Language:	Spanish
Published:	Elsevier 2025-07-01
Series:	Atención Primaria
Subjects:	Heart failure Left ventricular ejection fraction Primary health care Electronic Health records Renin-angiotensin system Heart failure with reduced left ventricular ejection fraction
Online Access:	http://www.sciencedirect.com/science/article/pii/S0212656724003470
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Adherence to treatment as an integral component of the management of patients with heart failure
by: V. N. Larina, et al.
Published: (2024-02-01)

Temporal left ventricular ejection fraction variations and outcomes in wide population of cardiovascular patients with and without heart failure
by: Radosław Szczerba, et al.
Published: (2025-03-01)

Characteristics, outcomes and the necessity of continued guideline-directed medical therapy in patients with heart failure with improved ejection fraction
by: Qin-Fen Chen, et al.
Published: (2025-12-01)

Prognostic value of atrial fibrillation in patients with heart failure and different left ventricular ejection fraction: results of the multicenter RIF-CHF register
by: I. V. Zhirov, et al.
Published: (2021-02-01)

Coronary Artery Disease Is A Stronger Predictor of All‐Cause Mortality Than Left Ventricular Ejection Fraction Among Patients With Newly Diagnosed Heart Failure: Insights From the WDHR
by: Roni Ranghoej Nielsen, et al.
Published: (2024-07-01)

Pharmacoepidemiological analysis of routine management of heart failure patients in the Russian Federation. Part I
by: Yu. M. Lopatin, et al.
Published: (2021-05-01)

Assessment of prevalence and monitoring of outcomes in patients with heart failure in Russia
by: E. V. Shlyakhto, et al.
Published: (2020-12-01)

Cardiorenal relationships in patients with chronic heart failure with preserved ejection fraction
by: Yu. N. Panina, et al.
Published: (2023-11-01)

Current diagnostic algorithms for chronic heart failure with preserved left ventricular ejection fraction
by: Ya. Yu. Maistrovych, et al.
Published: (2023-03-01)

Microcirculation in heart failure: state of the art (literature review)
by: I. M. Davidovich, et al.
Published: (2025-02-01)

Phenotypic clusters and biomarkers profile in patients with chronic heart failure with preserved and mildly reduced left ventricular ejection fraction
by: Natalia A. Dragomiretskaya, et al.
Published: (2024-12-01)

Clinical and anamnestic characteristics of patients depending on left ventricular ejection fraction: results of a register study
by: P. G. Parfenov, et al.
Published: (2024-07-01)

Survival after myocardial infarction according to left ventricular function and heart failure symptoms
by: Jarle Jortveit, et al.
Published: (2025-08-01)

Changes in left ventricular systolic function in patients with chronic heart failure with preserved ejection fraction and cardiorenal anemic syndrome.
by: V. A. Vasylenko
Published: (2015-09-01)

Efficacy of angiotensin receptor neprilysin inhibitor for maintenance hemodialysis patients with different types of left ventricular ejection fraction heart failure
by: Jin-cong Li, et al.
Published: (2024-12-01)

Changes in left ventricular systolic function in patients with chronic heart failure with preserved ejection fraction and cardiorenal anemic syndrome
by: Vasylenko V.A.
Published: (2015-09-01)

Fibroblast Growth Factor‐23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA
by: Mohamed Faher Almahmoud, et al.
Published: (2018-09-01)

Left ventricular global function index: prognostic value in patients with heart failure aged 60 years and older
by: V. N. Larina, et al.
Published: (2020-11-01)

Left ventricular systolic longitudinal strain in mechanically ventilated patients in the intensive care unit: assessment of global and chamber reproducibility
by: Matías Pécora, et al.
Published: (2025-06-01)

Modern echocardiographic criteria for heart failure with preserved ejection fraction: not only diastolic dysfunction
by: O. M. Drapkina, et al.
Published: (2020-04-01)

Medication adherence in patients with heart failure: a pilot observational study in outpatient practice
by: V. N. Larina, et al.
Published: (2024-12-01)

The Value of Biomarkers in the Diagnosis and Prognosis of Heart Failure in Older Age
by: V. N. Larina, et al.
Published: (2021-03-01)

Electrocardiograph analysis for risk assessment of heart failure with preserved ejection fraction: A deep learning model
by: Zheng Gao, et al.
Published: (2025-02-01)

Twenty-four-year-old patient with heart failure after myocarditis. Results of quadruple therapy: a case report
by: V. N. Larina, et al.
Published: (2023-04-01)

Effect of immunomodulation on cardiac remodelling and outcomes in heart failure: a quantitative synthesis of the literature
by: Navkaranbir S. Bajaj, et al.
Published: (2020-06-01)

Left ventricular ejection fraction decrease related to BRAF and/or MEK inhibitors in metastatic melanoma patients: A retrospective analysis
by: Mathilde Berger, et al.
Published: (2020-04-01)

Implantation of a cardiac contractility modulator in chronic heart failure and atrial fibrillation: results of a 6-month follow-up of one hundred patients
by: T. M. Uskach, et al.
Published: (2021-04-01)

Adverse effects of intracardiac dyssynchrony and right ventricular pacing on contractile function and prognosis
by: D. Yu. Andreev, et al.
Published: (2025-02-01)

EVALUATION OF DEFORMATION OF THE LEFT VENTRICLE AND LEFT ATRIUM, AND THE ROTATIONAL PROPERTIES OF THE LEFT VENTRICLE IN PATIENTS WITH CHF ACCORDING TO THE ECHOCARDIOGRAPHIC TECHNOLOGY OF NON-DOPPLER IMAGING IN TWO AND THREE-DIMENSIONAL REGIMENS
by: V. K. Sohibnazarova, et al.
Published: (2018-06-01)

Prognostic Value of the Global Left Ventricular Contractility Index in Patients with Severe Mitral Regurgitation and Preserved Left Ventricular Ejection Fraction
by: Tony Li, et al.
Published: (2025-06-01)

Cardiomyopathy in Non-Ambulatory Patients with Duchenne Muscular Dystrophy: Two Case Reports with Varying Outcomes, Considering Novel Treatments
by: Marcello Marcì, et al.
Published: (2024-12-01)

Clinical effect of three-dimensional left ventricular mechanical dyssynchrony and cardiac sympathetic denervation in systolic heart failure risk-stratified by left ventricular ejection fraction and QRS duration
by: Takahiro Doi, et al.
Published: (2025-06-01)

Baseline left ventricular ejection fraction predicts the magnitude of improvement in patients taking sacubitril/valsartan
by: José-Manuel Rubio-Campal, et al.
Published: (2025-06-01)

Left atrioventricular coupling index measured by echocardiography in heart failure with preserved ejection fraction
by: Hai Nguyen Ngoc Dang, et al.
Published: (2025-07-01)

Incidence and determinants of left ventricular ejection fraction (LVEF) recovery in heart failure with reduced ejection fraction (HFrEF) of non-ischemic aetiology; a hospital-based prospective longitudinal registry study
by: Sanjeev Kumar, et al.
Published: (2025-05-01)

Is there the phenotype of chronic heart failure with “intermediate” left ventricular ejection fraction? Additional echocardiographic criteria for left ventricular systolic dysfunction in patients with chronic heart failure of ischemic origin with ejection fraction in the “gray area”
by: V. V. Syvolap, et al.
Published: (2021-06-01)

Clinical Perspective of Myocardial Recovery and Improvement: Definitions, Prevalence, and Relevance
by: Anthony V. Pensa, et al.
Published: (2024-08-01)

Pharmacoepidemiological analysis of routine management of heart failure patients in the Russian Federation. Part II
by: S. V. Nedogoda, et al.
Published: (2022-03-01)

CORONARY ANGIOPLASTY AND STENTING IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY
by: A. N. Samko, et al.
Published: (2016-02-01)

Supramolecular complex sacubitril/valsartan - the first representative of a new class of drugs for the treatment of chronic heart failure
by: T. V. Ashcheulova, et al.
Published: (2019-12-01)